Finance

Lists
4118:TYO
Kaneka Corp
Â¥6,183.00
-0.03%
(-2.00) 1D
Aug 24, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4118...
Open
Â¥6,190
High
Â¥6,208
Low
Â¥6,155
Mkt. cap
389.53B
Avg. vol.
259.99K
Volume
207.10K
Dividend
2.59%
Quarterly dividend
Â¥40
Ex-dividend date
Sep 29, 2026
P/E ratio
10.60
52-wk high
Â¥6,570
52-wk low
Â¥4,082
EPS
Â¥583
Shares outstanding
65.56M
No. of employees
12K
Open
Â¥6,190
High
Â¥6,208
Low
Â¥6,155
Mkt. cap
389.53B
Avg. vol.
259.99K
Volume
207.10K
Dividend
2.59%
Quarterly dividend
Â¥40
Ex-dividend date
Sep 29, 2026
P/E ratio
10.60
52-wk high
Â¥6,570
52-wk low
Â¥4,082
EPS
Â¥583
Shares outstanding
65.56M
No. of employees
12K
Profile
Kaneka Corporation is a Japanese international chemical manufacturing company based in Osaka. The company was founded in 1949 and produces chemical products such as functional resin, foam resin, and synthetic fibers. The company was also engaged in the medical equipment business. In recent years, the company manufactured raw material for production of coenzyme Q10, and apheresis devices, where blood of a donor or patient is passed through an apparatus that separates out one particular constituent and returns the remainder to the circulation. Wikipedia
About Kaneka Corp
CEO-
Employees11.8K
FoundedSep 1, 1949
Headquarters-
SectorCommodity chemical
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
198.75B
200.85B
213.36B
223.02B
Cost of goods sold
144.43B
144.80B
152.38B
157.45B
Cost of revenue
144.43B
144.80B
152.38B
157.45B
Research and development expenses
-
-
39.89B
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
47.51B
48.81B
847.00M
50.64B
Operating expense
47.51B
48.81B
51.54B
50.64B
Total operating expenses
191.94B
193.62B
203.92B
208.08B
Operating income
6.80B
7.23B
9.44B
14.94B
Other non operating income
-332.00M
-340.00M
1.29B
-222.00M
EBT including unusual items
9.96B
11.33B
16.62B
13.42B
EBT excluding unusual items
6.27B
7.98B
10.87B
14.69B
Income tax expense
2.74B
3.58B
3.60B
3.92B
Effective tax rate
27.56%
31.57%
21.67%
29.24%
Other operating expenses
-
-
-
-
Net income
6.79B
7.39B
12.54B
8.94B
Net profit margin
3.42%
3.68%
5.88%
4.01%
Earnings per share
-
-
-
-
Interest and investment income
235.00M
771.00M
385.00M
675.00M
Interest expense
-1.01B
-1.00B
-1.07B
-1.09B
Net interest expenses
-775.00M
-229.00M
-682.00M
-419.00M
Depreciation and amortization charges
-
-
10.80B
-
EBITDA
18.40B
18.22B
21.30B
26.80B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps